Elimination of cotinine from body fluids: disposition in smokers and nonsmokers
- PMID: 2751025
- PMCID: PMC1349908
- DOI: 10.2105/ajph.79.8.1046
Elimination of cotinine from body fluids: disposition in smokers and nonsmokers
Abstract
We have evaluated differences in the elimination of cotinine, a major nicotine metabolite, in smokers who quit smoking and never-smokers who were exposed to environmental tobacco smoke (ETS) under controlled conditions. The mean biological half-life of cotinine in urine, collected from the nine smokers was 16.5 +/- 1.2 h, in never-smokers exposed to ETS, 27.3 +/- 1.9 h. Differences in the mode of uptake and absorption of nicotine and possible differences in nicotine metabolism may play roles in the clearance rate differences between smokers and nonsmokers.
Similar articles
-
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.Am J Public Health. 1988 Jun;78(6):696-8. doi: 10.2105/ajph.78.6.696. Am J Public Health. 1988. PMID: 3369603 Free PMC article.
-
Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine.Clin Pharmacol Ther. 1990 Dec;48(6):641-51. doi: 10.1038/clpt.1990.208. Clin Pharmacol Ther. 1990. PMID: 2249376
-
Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.Clin Pharmacol Ther. 1993 Mar;53(3):316-23. doi: 10.1038/clpt.1993.27. Clin Pharmacol Ther. 1993. PMID: 8453850
-
[Toxicologic and pharmacologic methods in the control of smoking behavior].Z Erkr Atmungsorgane. 1989;173(2):127-33. Z Erkr Atmungsorgane. 1989. PMID: 2686221 Review. German.
-
Uptake of environmental tobacco smoke.IARC Sci Publ. 1987;(81):43-58. IARC Sci Publ. 1987. PMID: 3323054 Review.
Cited by
-
Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation.Genet Res (Camb). 2022 Sep 28;2022:2917881. doi: 10.1155/2022/2917881. eCollection 2022. Genet Res (Camb). 2022. PMID: 36245555 Free PMC article.
-
Decreasing urinary PAH metabolites and 7-methylguanine after smoking cessation.Int Arch Occup Environ Health. 2006 Aug;79(7):545-9. doi: 10.1007/s00420-005-0071-6. Epub 2006 Jan 11. Int Arch Occup Environ Health. 2006. PMID: 16404638
-
Biomarkers of Exposure Among "Dual Users" of Tobacco Cigarettes and Electronic Cigarettes in Canada.Nicotine Tob Res. 2019 Aug 19;21(9):1259-1266. doi: 10.1093/ntr/nty174. Nicotine Tob Res. 2019. PMID: 30203076 Free PMC article. Clinical Trial.
-
The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.Pharmacogenet Genomics. 2013 Dec;23(12):706-16. doi: 10.1097/FPC.0000000000000011. Pharmacogenet Genomics. 2013. PMID: 24192532 Free PMC article.
-
Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study.Cancer. 2007 Jun 15;109(12):2547-56. doi: 10.1002/cncr.22724. Cancer. 2007. PMID: 17492688 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources